{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:53:32Z","timestamp":1787756012744,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd008550.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000}}],"reference-count":131,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008550.pub3","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:31:39Z","timestamp":1692725499000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological treatment of gastro-oesophageal reflux in children"],"prefix":"10.1002","volume":"2023","author":[{"given":"Mark P","family":"Tighe","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; University Hospitals Dorset; Poole UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Andrews","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; University Hospitals Dorset; Poole UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Liddicoat","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; University Hospitals Dorset; Poole UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem A","family":"Afzal","sequence":"additional","affiliation":[{"name":"Faculty of Science & Health; Portsmouth University; Portsmouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hayen","sequence":"additional","affiliation":[{"name":"Australian Centre for Public and Population Health, Faculty of Health; University of Technology Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Mark","family":"Beattie","sequence":"additional","affiliation":[{"name":"Child Health; University Hospital Southampton NHS Foundation Trust; Southampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3345\/kjp.2016.59.5.226","article-title":"Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants","volume":"59","author":"Azizollahi","year":"2016","journal-title":"Korean Journal of Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0009922810369253","article-title":"Clinical results from a randomised, double-blind, dose-ranging study of pantoprazole in children aged 1 through 5 years with symptomatic histologic or erosive esophagitis","volume":"49","author":"Baker","year":"2010","journal-title":"Clinical Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/ijerph17010083","article-title":"Magnesium alginate in gastro-esophageal reflux: a randomized multicenter cross-over study in infants","volume":"17","author":"Baldassarre","year":"2020","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/MPG.0000000000002086","article-title":"Erythromycin and reflux events in premature neonates: a randomized clinical trial","volume":"67","author":"Ballengee","year":"2018","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0005|cit5","first-page":"400","article-title":"Efficacy of domperidone in infants and children with gastroesophageal reflux","volume":"14","author":"Bines","year":"1992","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0006|cit6","first-page":"304","article-title":"Efficacy of combined administration of an alginate formulation (Gaviscon) and Lansoprazole for children with gastroesophageal reflux","volume":"28","author":"Borrelli","year":"2002","journal-title":"Italian Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02343223","article-title":"Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children","volume":"146","author":"Buts","year":"1987","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365529409094839","article-title":"Domperidone plus magnesium hydroxide and aluminium hydroxide: a valid therapy in children with gastroesophageal reflux","volume":"29","author":"Carroccio","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/jp.2008.81","article-title":"Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring","volume":"28","author":"Cresi","year":"2008","journal-title":"Journal of Perinatology"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/adc.59.9.842","article-title":"Antacids and cimetidine treatment for gastrooesophageal reflux and peptic oesophagitis","volume":"59","author":"Cucchiara","year":"1984","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/adc.69.6.655","article-title":"Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis","volume":"69","author":"Cucchiara","year":"1993","journal-title":"Archives of Disease in Childhood"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpeds.2013.05.007","article-title":"Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients","volume":"163","author":"Davidson","year":"2013","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/adc.2002.024463","article-title":"Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance\/pH","volume":"90","author":"Del Buono","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"e5343","DOI":"10.5812\/ijp.5343","article-title":"Comparison of hypoallergenic diet vs. ranitidine in treatment of gastroesophageal reflux disease of infants: a randomized clinical trial","volume":"27","author":"Famouri","year":"2017","journal-title":"Iranian Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0015|cit15","first-page":"556","article-title":"The effects of gaviscon and metoclopramide in gastroesophageal reflux in children","volume":"5","author":"Forbes","year":"1986","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1097\/00005176-200610000-00051","article-title":"Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease","volume":"43","author":"Gilger","year":"2006","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0017|cit17","first-page":"S16","article-title":"Safety and tolerability of esomeprazole in children with gastro-esophageal reflux disease","volume":"46","author":"Gilger","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1097\/00005176-200211004-00005","article-title":"Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability","volume":"35","author":"Gunasekaran","year":"2002","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MPG.0b013e3182a4e718","article-title":"Efficacy and safety of rabeprazole in children (1-11 years) with gastroesophageal reflux disease","volume":"57","author":"Haddad","year":"2013","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MPG.0000000000000195","article-title":"Safety and efficacy of delayed release rabeprazole in 1- to 11-month-old infants with symptomatic GERD","volume":"58","author":"Hussain","year":"2014","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10620-010-1321-3","article-title":"Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1-11 months with a clinical diagnosis of gastroesophageal reflux disease","volume":"56","author":"Kierkus","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MPG.0000000000000395","article-title":"Body positioning and medical therapy for infantile gastroesophageal reflux symptoms","volume":"59","author":"Loots","year":"2014","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1185\/03007999909114087","article-title":"Comparison of the efficacy and safety of a new aluminum-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux","volume":"15","author":"Miller","year":"1999","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/S0022-3476(03)00207-5","article-title":"Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux","volume":"143","author":"Moore","year":"2003","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ctim.2019.06.007","article-title":"Comparison of the efficacy of ranitidine and quince syrup on gastroesophageal reflux disease in children","volume":"45","author":"Naeimi","year":"2019","journal-title":"Complementary Therapies in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jpeds.2006.05.029","article-title":"Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trial","volume":"149","author":"Omari","year":"2006","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MPG.0b013e31812e012f","article-title":"Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease","volume":"45","author":"Omari","year":"2007","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.mpg.0000469415.50085.f7","article-title":"Pharmacokinetics and acid-suppressive effects of esomeprazole in infants 1-24 months old with symptoms of gastroesophageal reflux disease","volume":"60","author":"Omari","year":"2015","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1365-2036.2003.01559.x","article-title":"Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial","volume":"17","author":"Orenstein","year":"2003","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jpeds.2008.09.054","article-title":"Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease","volume":"154","author":"Orenstein","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01.mpg.0000189354.48043.4e","article-title":"Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors","volume":"42","author":"Pfefferkorn","year":"2006","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0032|cit32","first-page":"51","article-title":"Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine","volume":"25","author":"Simeone","year":"1997","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.mpg.0000214160.37574.d3","article-title":"Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease","volume":"42","author":"Tolia","year":"2006","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MPG.0b013e3181ddcf11","article-title":"Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old","volume":"51","author":"Tolia","year":"2010","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2431-10-41","article-title":"Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study","volume":"10","author":"Tolia","year":"2010","journal-title":"BMC Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0036|cit36","first-page":"S24","article-title":"Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study","volume":"10","author":"Tolia","year":"2015","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD008550.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/0009922806292792","article-title":"Multicenter, randomized, double-blind study comparing 20 and 40 mg of pantoprazole for symptom relief in adolescents (12 to 16 years of age) with gastroesophageal reflux disease (GERD)","volume":"45","author":"Tsou","year":"2006","journal-title":"Clinical Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MPG.0000000000000521","article-title":"Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants","volume":"60","author":"Ummarino","year":"2015","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ctcp.2015.09.005","article-title":"Effects of quince syrup on clinical symptoms of children with symptomatic gastroesophageal reflux disease: a double-blind randomized controlled clinical trial","volume":"21","author":"Zohalinezhad","year":"2015","journal-title":"Complementary Therapies in Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0040|cit40","first-page":"1439","article-title":"Efficacy of quince (Cydonia oblonga M) syrup in symptomatic gastroesophageal reflux disease: a double-blind randomized controlled clinical trial","volume":"82","author":"Zohalinezhad","year":"2016","journal-title":"Planta Medica"},{"issue":"Suppl 57","key":"10.1002\/14651858.CD008550.pub3-BIB0041|cit41","first-page":"1138","article-title":"Esomeprazole, versus esomeprazole and domperidone in treatment of gastroesophageal reflux in children with difficult-to-treat asthma","volume":"42","author":"Al-Biltagi","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00148581-200608040-00005","article-title":"Ranitidine (Zantac) syrup vs ranitidine effervescent tablets (Zantac EFFERdose) in children, a single-center taste preference study","volume":"8","author":"Ameen","year":"2006","journal-title":"Pediatric Drugs"},{"issue":"S1","key":"10.1002\/14651858.CD008550.pub3-BIB0043|cit43","first-page":"S22","article-title":"Rectal omeprazole in young infants: the magic bullet","volume":"101","author":"Bestebreurtje","year":"2017","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13318-020-00630-8","article-title":"Rectal omeprazole in infants with gastroesophageal reflux disease: a randomized pilot trial","volume":"45","author":"Bestebreurtje","year":"2020","journal-title":"European Journal of Drug Metabalism and Pharmacokinetics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2036.2010.04545.x","article-title":"The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants","volume":"33","author":"Corvaglia","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2004.tb00680.x","article-title":"Diagnosis and management of gastro-oesophageal reflux in preterm infants in neonatal intensive care units","volume":"93","author":"Dhillon","year":"2004","journal-title":"Acta Paediatrica"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.MPG.0000155369.54464.41","article-title":"Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastro-oesophageal reflux disease","volume":"40","author":"Fiedorek","year":"2005","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"8","key":"10.1002\/14651858.CD008550.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S1590-8658(00)80326-6","article-title":"Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood","volume":"32","author":"Franco","year":"2000","journal-title":"Digestive and Liver Disease"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0049|cit49","first-page":"332","article-title":"Efficacy and safety of omeprazole for severe gastroesophageal reflux in children","volume":"124","author":"Gunasekaran","year":"1994","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MPG.0000000000000229","article-title":"Maintenance of efficacy and safety of rabeprazole in children with endoscopically proven GERD","volume":"58","author":"Haddad","year":"2014","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1067\/mpd.2000.109607","article-title":"Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy safety, tolerability and dose requirements","volume":"137","author":"Hassall","year":"2000","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2036.2011.04950.x","article-title":"Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study","volume":"35","author":"Hassall","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.clinthera.2007.09.007","article-title":"Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: an open-label, single- and multiple-dose study","volume":"29","author":"James","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD008550.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0166207","article-title":"Dose-finding study of omeprazole on gastric pH in neonates with gastro-esophageal acid reflux using a Bayesian sequential approach","volume":"11","author":"Kaguelidou","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MPG.0b013e31822a323a","article-title":"Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERD","volume":"54","author":"Kukulka","year":"2012","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0056|cit56","unstructured":"Kushki AM Study of the effect of Esomeprazole and combination of Esomeprazole plus Baclofen in the treatment of clinical signs of infants reflux [sic] Iranian Registry of Clinical Trials 2021"},{"issue":"11","key":"10.1002\/14651858.CD008550.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.clinthera.2006.11.012","article-title":"Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study","volume":"28","author":"Li","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0058|cit58","first-page":"S68","article-title":"Esophageal impedance baselines in infants before and after placebo, antacid and proton pump inhibitor therapy","volume":"53","author":"Loots","year":"2011","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0059|cit59","first-page":"261","article-title":"Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children","volume":"36","author":"Madrazo-de la Garza","year":"2003","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2008-1066506","article-title":"The use of omeprazole for resistant oesophagitis in children","volume":"6","author":"Martin","year":"1996","journal-title":"European Journal of Pediatric Surgery"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/j.1536-4801.2004.tb00871.x","article-title":"Severe gastroesophageal reflux disease and cow milk hypersensitivity in infants and children: disease association and evaluation of a new challenge procedure","volume":"39","author":"Nielsen","year":"2004","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jpeds.2009.02.025","article-title":"Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease","volume":"155","author":"Omari","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD008550.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinthera.2005.04.008","article-title":"Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children","volume":"27","author":"Orenstein","year":"2005","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0064|cit64","first-page":"111","article-title":"Gastric acid suppression of a new oral powder omeprazole suspension for infants with gastroesophageal reflux disease. A pilot study","volume":"41","author":"Orsi","year":"2011","journal-title":"Acta Gastroenterologica Latinoamericana"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0065|cit65","unstructured":"Protonix (Pantoprazole) treatment of maintenance of healing in pediatric participants aged 1-11 years and 12-17 years clinicaltrials.gov\/ct2\/show\/NCT04821310"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"A234","DOI":"10.1136\/archdischild-2016-310863.391","article-title":"G401 (P) Evaluation of gastroesophageal reflux disease in neonates pre and post proton pump inhibitors therapy using oesophageal multichannel intraluminal impedance and PH monitoring","volume":"101 (Suppl)","author":"Rabie","year":"2016","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0067|cit67","unstructured":"Effect of omeprazole and es-omeprazole in reflux disease [sic] trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20191027045256N1"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1651-2227.2006.tb02203.x","article-title":"Oral ranitidine and duration of gastric pH <4.0 in infants with persisting reflux symptoms","volume":"95","author":"Salvatore","year":"2006","journal-title":"Acta Paediatrica"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40272-018-0314-0","article-title":"The effect of alginate in gastroesophageal reflux in infants","volume":"20","author":"Salvatore","year":"2018","journal-title":"Paediatric Drugs"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/adc.2004.068890","article-title":"Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease","volume":"90","author":"St\u00f8rdal","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"8","key":"10.1002\/14651858.CD008550.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11591900-000000000-00000","article-title":"Randomized, open-label, multicentre pharmacokinetic studies of two dose levels of pantoprazole granules in infants and children aged 1 month through < 6 years with gastro-oesophageal reflux disease","volume":"50","author":"Tammara","year":"2011","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1542\/peds.2011-0796","article-title":"Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns","volume":"129","author":"Terrin","year":"2012","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1097\/00005176-200211004-00003","article-title":"Efficacy of lansoprazole in the treatment of gastrooesophageal reflux in children","volume":"35","author":"Tolia","year":"2002","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1067\/mcp.2002.122472","article-title":"Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children","volume":"71","author":"Tran","year":"2002","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0075|cit75","first-page":"S69","article-title":"Effect of lansoprazole plus domperidone for treatment of gastroesophageal reflux disease in infants","volume":"53","author":"Treepongkaruna","year":"2011","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/0091270010377501","article-title":"A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease","volume":"51","author":"Ward","year":"2011","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MPG.0b013e3181c2bf41","article-title":"Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD","volume":"50","author":"Winter","year":"2010","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/j.1536-4801.2012.tb00025.x","article-title":"Esomeprazole for the treatment of GERD in infants ages 1-11 months","volume":"55","author":"Winter","year":"2012","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/MPG.0b013e3182496b35","article-title":"Esomeprazole for the treatment of GERD in infants ages 1-11 months","volume":"60","author":"Winter","year":"2015","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/MPG.0b013e318207834d","article-title":"Pharmacokinetics and tolerability of rabeprazole in children 1 to 11 years old with gastroesophageal reflux disease","volume":"52","author":"Zannikos","year":"2011","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD008550.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.clinthera.2006.11.012","article-title":"Pharmacokinetic properties of esomeprazole in children aged 1 to 11 years with symptoms of gastroesophageal reflux disease: a randomized, open-label study","volume":"28","author":"Zhao","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD008550.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1002\/ptr.7288","article-title":"Myrtle (Myrtus communis L.) fruit syrup for gastroesophageal reflux disease in children: a double-blind randomized clinical trial","volume":"35","author":"Paknejad","year":"2021","journal-title":"Phytotherapy Research"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0083|cit83","first-page":"11287","article-title":"The efficacy of baclofan to treat gastroesophageal reflux disease in children aged 6 months to 12 years: a clinical trial study","volume":"8","author":"Sobhani Shahmirzadi","year":"2020","journal-title":"International Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002300","article-title":"Cisapride treatment for gastrooesophageal reflux in children","author":"Augood","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1007\/s10620-016-4333-9","article-title":"Adverse effects of domperidone: prolonged quest for knowledge?","volume":"61","author":"Bashashati","year":"2016","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0086|cit86","volume-title":"British National Formulary for Children","author":"British Medical Association","year":"2021"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1542\/peds.2007-3569","article-title":"Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey","volume":"123","author":"Campanozzi","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0088|cit88","first-page":"9","article-title":"Cisapride (Propulsid) withdrawn","volume":"26","author":"Committee on Safety of Medicines and Medicines Control Agency","year":"2000","journal-title":"Curr Prob Pharmacovigil"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/archpedi.156.7.647","article-title":"Very early exposure to erythromycin andinfantile hypertrophic pyloric stenosis","volume":"156","author":"Cooper","year":"2002","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003502.pub3","article-title":"Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two years","author":"Craig","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/archdischild-2017-314026","article-title":"Toxicity of long-term use of proton pump inhibitors in children","volume":"103","author":"De Bruyne","year":"2018","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0092|cit92","unstructured":"European Medicine Agency Committee on Medicinal Products for Human Use European Medicines Agency recommends changes to the use of metoclopramide www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/07\/news_detail_001854.jsp&mid=WC0b01ac058004d5c1"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0093|cit93","unstructured":"European Medicines Agency PRAC recommends restricting use of domperidone; March 2014 www.ema.europa.eu\/en\/news\/prac-recommends-restricting-use-domperidone\\"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0094|cit94","unstructured":"FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs [press release] Food and Drug Administration; Rockville, MD 2009"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0095|cit95","unstructured":"Fitzgerald JF Vasundhara T Fraga P Peters S Donnelly C Mack M Age-specific questionaires distinguish symptom frequency and severity in young children with and without gastroesophageal reflux disease Sixteenth Annual Meeting of NASPGHAN Poster, Montreal, Quebec 2003"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/MPG.0000000000002690","article-title":"The clinical characteristics of fractures in pediatric patients exposed to proton pump inhibitors","volume":"70","author":"Fleishman","year":"2020","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0097|cit97","first-page":"285","article-title":"Acute extrapyramidal dysfunction after domperidone administration: Report of a case","volume":"39","author":"Franckx","year":"1984","journal-title":"Helvetica Paediatrica Acta"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0098|cit98","unstructured":"Reckitt Benckiser Healthcare (UK) Limited Gaviscon Product Information Reckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull"},{"issue":"10","key":"10.1002\/14651858.CD008550.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/adc.2004.069674","article-title":"Outcomes of fundoplication: causes for concern, newer options","volume":"90","author":"Hassall","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"7414","key":"10.1002\/14651858.CD008550.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0101|cit101","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0102|cit102","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.3. Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0103|cit103","first-page":"52","article-title":"Clinical and laboratory correlates of esophagitis","volume":"7","author":"Hyams","year":"1988","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1456\u201368","DOI":"10.1053\/j.gastro.2016.02.015","article-title":"Childhood functional gastrointestinal disorders: child\/adolescent","volume":"150","author":"Hyams","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0105|cit105","first-page":"1426","article-title":"Ranitidine tachyphylaxis","volume":"88","author":"Hyman","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0106|cit106","first-page":"ep114","article-title":"Update on drugs for gastro-oesophageal reflux disease","volume":"92","author":"Keady","year":"2007","journal-title":"Archives of Disease in Childhood"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MPG.0b013e318205970e","article-title":"Development and psychometric evaluation of 2 age-stratified versions of the Pediatric GERD Symptom and Quality of Life Questionnaire","volume":"52","author":"Kleinman","year":"2011","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0108|cit108","first-page":"CD003211","article-title":"Feed thickener for infants up to six months of age with gastro-oesophageal reflux","volume":"12","author":"Kwok","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD008550.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2036.2000.00759.x","article-title":"Review article: alginate-raft formulations in the treatment of heartburn and acid reflux","volume":"14","author":"Mandel","year":"2000","journal-title":"Alimentary Pharmacology Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1542\/peds.109.6.1061","article-title":"Natural history and familial relationships of infant spilling to 9 years of age","volume":"109","author":"Martin","year":"2002","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4292\/wjgpt.v5.i2.57","article-title":"Histamine2-receptor antagonists: rapid development of tachyphylaxis with repeat dosing","volume":"5","author":"McRorie","year":"2014","journal-title":"World Journal of Gastrointestinal Pharmacology and Therapeutics"},{"issue":"9","key":"10.1002\/14651858.CD008550.pub3-BIB0113|cit113","first-page":"1","article-title":"Proton pump inhibitors in long-term use: reports of hypomagnesaemia","volume":"5","author":"Medicines Health Regulatory Authority","year":"2012","journal-title":"Drug Safety Update"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0114|cit114","unstructured":"Medicines and Healthcare products Regulatory Agency. Ranitidine \u2013 MHRA drug alert issued for Teva UK recall, 2019 Available at: https:\/\/www.gov.uk\/government\/news\/ ranitidine-mhra-drug-alert-issued-for-teva-uk-recall"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1442-200X.2002.01609.x","article-title":"Prevalence of gastro-esophageal reflux-related symptoms in Japanese infants","volume":"44","author":"Miyazawa","year":"2002","journal-title":"Pediatrics International"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0b013e3181b7f563","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"66","author":"Rosen","year":"2018","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archpedi.1997.02170430035007","article-title":"Prevalence of symptoms of gastro-oesophageal reflux during infancy: a paediatric practice-based survey","volume":"151","author":"Nelson","year":"1997","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0118|cit118","unstructured":"National Institute for Health and Care Excellence Gastro-oesophageal reflux disease in children and young people: diagnosis and management (NG1); October 2019 www.nice.org.uk\/guidance\/ng1"},{"issue":"6","key":"10.1002\/14651858.CD008550.pub3-BIB0119|cit119","first-page":"431\u20136","article-title":"Symptoms and reflux in infants: Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R): utility for symptom tracking and diagnosis","volume":"12","author":"Orenstein","journal-title":"Curr Gastroenterol Rep."},{"key":"10.1002\/14651858.CD008550.pub3-BIB0120|cit120","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). Cochrane, 2020 www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0121|cit121","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2019"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0122|cit122","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamainternmed.2015.7927","article-title":"Adverse effects associated with proton pump inhibitors","volume":"176","author":"Schoenfeld","year":"2016","journal-title":"JAMA Intern Med."},{"key":"10.1002\/14651858.CD008550.pub3-BIB0124|cit124","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from guidelinedevelopment.org\/handbook Available from guidelinedevelopment.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD008550.pub3-BIB0125|cit125","first-page":"95","article-title":"Oculogyric crisis due to domperidone therapy","volume":"40","author":"Shafrir","year":"1985","journal-title":"Helvetica Paediatrica Acta"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ajg.2009.129","article-title":"A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population","volume":"104","author":"Sherman","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD008550.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00148581-200911030-00004","article-title":"Current pharmacological management of gastro-esophageal reflux in children","volume":"11","author":"Tighe","year":"2009","journal-title":"Pediatric Drugs"},{"issue":"5","key":"10.1002\/14651858.CD008550.pub3-BIB0128|cit128","first-page":"375","article-title":"Diagnosis and treatment of gastroesophageal reflux disease in infants and children","volume":"5","author":"Vandenplas","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1002\/14651858.CD008550.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","article-title":"Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics","volume":"15","author":"Ward","journal-title":"Paediatr Drugs"},{"key":"10.1002\/14651858.CD008550.pub3-BIB0130|cit130","unstructured":"Country and Lending Groups classification of countries by income datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html"},{"issue":"11","key":"10.1002\/14651858.CD008550.pub3-BIB0131|cit131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008550.pub2","article-title":"Pharmacological treatment of children with gastro-oesophageal reflux","author":"Tighe","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T12:36:35Z","timestamp":1718973395000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008550.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gut Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":131,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008550.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}